United States · FDA National Drug Code directory
fondaparinux sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1514_4234bd9e-7f61-2cb0-e063-6294a90a4e14
- Product NDC
- 70710-1514
- Form
- INJECTION, SOLUTION
- Composition / generic term
- fondaparinux sodium
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190206
- Source listing expiry
- 20261231
Source-listed ingredients
- FONDAPARINUX SODIUM — 2.5 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (70710-1514-6) / .5 mL in 1 SYRINGE (70710-1514-2) · 70710-1514-6
- 2 SYRINGE in 1 CARTON (70710-1514-9) / .5 mL in 1 SYRINGE (70710-1514-2) · 70710-1514-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →